Tiantu Capital Leads $145M Series B Round In Chinese Home Furnishing Platform Aijia

Technology

AstraZeneca Plans to Seek Regulatory Approval for COPD Drug PT010 Following Phase III Trial

Life Science

Shanghai Introduces Measures To Boost AI Industry Via Talent, Data, Capital

Technology

R&D Cooperation Between China and Western Pharma Companies Up 70 Percent

Life Science

Hua Medicine Stages $110 Million Hong Kong IPO at $1.1 Billion Valuation

Life Science

China Renaissance Seeks Up to $377M In Hong Kong IPO

Technology

Shanghai Pharma Signs MOU to Develop BIOCAD’s mAb Portfolio in China

Life Science

Vivo Capital Closes Latest US-China PE Fund at $635 Million

Life Science

Tencent-backed Meituan raises $4.2 billion in IPO priced near top of range: sources

Technology

Hong Kong Ups Support To Start-Ups As Government Increase Capital Allocation To Tech Firms

Technology

First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody as First-line Treatment for Patients with Non-Squamous Non-Small Cell Lung Cancer

Life Science

Tianjin Tasly Out-licenses US Rights to TCM Angina Drug in $50 Million Deal

Life Science

SBCVC’s USD1 Billion Pumped Into SenseTime Raises its Value to USD6 Billion

Technology

Aurora Cannabis’ $290-million deal to buy ICC Labs fuels surge in marijuana stocks

Cannabis, Life Science

Russia-China to invest in hi-tech development

Technology